Human herpesvirus 8 glycoprotein B (gB), gH, and gL can mediate cell fusion

Journal of Virology

Volumn 76, Issue 9, 2002, Pages 4390-4400

  Pertel, Peter E ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN B; GLYCOPROTEIN GH; GLYCORPOTEIN GL; LUCIFERASE; RNA POLYMERASE; UNCLASSIFIED DRUG; VIRUS GLYCOPROTEIN;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; CELL FUSION; CELL MEMBRANE; CONTROLLED STUDY; EMBRYO; EMBRYO CELL; ENDOCYTOSIS; GENE DELETION; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 8; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REPORTER GENE; SIGNAL TRANSDUCTION; VIRUS ENVELOPE;

AMINO ACID SEQUENCE; ANIMALS; B-LYMPHOCYTES; CELL LINE; CHO CELLS; CRICETINAE; HERPESVIRUS 8, HUMAN; HUMANS; MEMBRANE FUSION; MOLECULAR SEQUENCE DATA; TRANSFECTION; VIRAL ENVELOPE PROTEINS;

EID: 0036226223     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.76.9.4390-4400.2002     Document Type: Article

References (73)

1. Human herpesvirus 8 envelope-associated glycoprotein B interacts with heparan sulfate-like moieties
2. Human herpesvirus 8 interaction with target cells involves heparan sulfate
3. Herpes-like sequences in HIV-infected and uninfected Kaposi's sarcoma patients
4. Truncation of the carboxy-terminal 28 amino acids of glycoprotein B specified by herpes simplex virus type 1 mutant amb1511-7 causes extensive cell fusion
5. Glycoprotein B of human herpesvirus 8 is a component of the virion in a cleaved form composed of amino- and carboxyl-terminal fragments
6. Cell surface heparan sulfate is a receptor for human herpesvirus 8 and interacts with envelope glycoprotein K8.1
7. The restricted cellular host range of human herpesvirus 8
8. Monocytes in Kaposi's sarcoma lesions are productively infected by human herpesvirus 8
9. Structural domains involved in human cytomegalovirus glycoprotein B-mediated cell-cell fusion
10. Kaposi's sarcoma-associated herpesvirus infects endothelial and spindle cells
11. Nucleotide sequence of a region of the herpes simplex virus type 1 gB glycoprotein gene: Mutations affecting rate of virus entry and cell fusion
12. Human herpesvirus-8 ORF K8.1 gene encodes immunogenic glyco-proteins generated by spliced transcripts
13. Reactivities of human sera with human herpesvirus-8-infected BCBL-1 cells and identification of HHV-8-specific proteins and glycoproteins and the encoding cDNAs
14. Early events in human herpesvirus infection of cells
15. Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system
16. Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma
17. Cell surface expression and fusion by the varicella-zoster virus gH:gL glycoprotein complex: Analysis by laser scanning confocal microscopy
18. Transformation of primary human endothelial cells by Kaposi's sarcoma associated herpesvirus
19. Propagation of a human herpesvirus from AIDS-associated Kaposi's sarcoma
20. Construction and properties of a mutant of herpes simplex virus type 1 with glycoprotein H coding sequences deleted
21. Distinct biology of Kaposi's sarcoma-associated herpesvirus from primary lesions and body cavity lymphomas
22. Glycoprotein B of bovine herpesvirus 4: Its phylogenetic relationship to gB equivalents of the herpesviruses
23. Conservation of glycoprotein H (gH) in herpesviruses: Nucleotide sequence of the gH gene from herpesvirus saimiri
24. Different functional domains in the cytoplasmic tail of glycoprotein B are involved in Epstein-Barr virus-induced membrane fusion
25. Cytoplasmic domain signal sequences that mediate transport of varicella-zoster virus gB from the endoplasmic reticulum to the Golgi
26. Glycoprotein 110, the Epstein-Barr virus homolog of herpes simplex virus glycoprotein B, is essential for Epstein-Barr virus replication in vivo
27. A novel herpes simplex virus glycoprotein, gL, forms a complex with glycoprotein H (gH) and affects normal folding and surface expression of gH
28. Monensin inhibits the processing of herpes simplex virus glycoproteins, their transport to the cell surface, and the egress of virions from infected cells
29. Identification and characterization of a bovine herpesvirus-1 (BHV-1) glycoprotein gL which is required for proper antigenicity, processing, and transport of BHV-1 glycoprotein gH
30. Surface IgM-kappa specificity on a Burkitt lymphoma cell in vivo and in derived culture lines
31. Pseudorabies virus glycoprotein L is necessary for virus infectivity but dispensable for virion localization of glycoprotein H
32. Pseudorabies virus glycoprotein M inhibits membrane fusion
33. Neuraminidase hemadsorption activity, conserved in avian influenza A viruses, does not influence viral replication in ducks
34. The Epstein-Barr virus glycoprotein 110 carboxy-terminal tail domain is essential for lytic virus replication
35. Chaperone functions common to nonhomologous Epstein-Barr virus gL and varicellazoster virus gL proteins
36. The Epstein-Barr virus (EBV) BZLF2 gene product associates with the gH and gL homologs of EBV and carries an epitope critical to infection of B cells but not of epithelial cells
37. Identification and expression of the human herpesvirus 6 glycoprotein H and interaction with an accessory 40K glycoprotein
38. The only domain which distinguishes Epstein-Barr virus latent membrane protein 2A (LMP2A) from LMP2B is dispensable for lymphocyte infection and growth transformation in vitro; LMP2A is therefore nonessential
39. + T lymphocytes
40. The structural era of endocytosis
41. Establishment and characterization of an Epstein-Barr virus (EBV)-negative lymphoblastoid B cell line (BJA-B) from an exceptional, EBV-genome-negative African Burkitt's lymphoma
42. Unidirectional complementation between glycoprotein B homologues of pseudo-rabies virus and bovine herpesvirus 1 is determined by the carboxy-terminal part of the molecule
43. Primary characterization of a herpesvirus agent associated with Kaposi's sarcoma
44. Long-term infection and transformation of dermal microvascular endothelial cells by human herpesvirus 8
45. Characterization of cell-cell fusion mediated by herpes simplex virus 2 glycoproteins gB, gD, gH, and gL in transfected cells
46. Identification of gp350 as the viral glycoprotein mediating attachment of Epstein-Bart virus (EBV) to the EBV/C3d receptor of B cells: Sequence homology of gp350 and C3 complement fragment C3d
47. Efficient selection for high-expression transfectants with a novel eukaryotic vector
48. Effects of truncation of the carboxy terminus of pseudorabies virus glycoprotein B on infectivity
49. Host range of human T-cell leukemia virus type I analyzed by a cell fusion-dependent reporter gene activation assay
50. Pseudorabies virus envelope glycoproteins gp50 and gII are essential for virus penetration, but only gII is involved in membrane fusion
51. Function of glycoprotein B homologues of the family Herpesviridae
52. Cell fusion induced by herpes simplex virus glycoproteins gB, gD, and gH-gL requires a gD receptor but not necessarily heparan sulfate
53. Human herpesvirus-8 glycoprotein B interacts with Epstein-Barr virus (EBV) glycoprotein 110 but fails to complement the infectivity of EBV mutants
54. The immunogenic glycoprotein gp35-37 of human herpesvirus 8 is encoded by open reading frame K8.1
55. The 222- to 234-kilodalton latent nuclear protein (LNA) of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) is encoded by orf73 and is a component of the latency-associated nuclear antigen
56. Pseudorabies virus glycoproteins gII and gp50 are essential for virus penetration
57. Limited transmission of Kaposi's sarcoma-associated herpesvirus in cultured cells
58. Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture
59. A mutant herpes simplex virus type 1 unable to express glycoprotein L cannot enter cells, and its particles lack glycoprotein H
60. Nucleotide sequence of the Kaposi sarcoma -associated herpesvirus (HHV8)
61. Coexpression of truncated human cytomegalovirus gH with the UL115 gene product or the truncated human fibroblast growth factor receptor results in transport of gH to the cell surface
62. Entry of alphaherpesviruses into cells
63. Membrane fusion induced by herpes simplex virus
64. Kaposi's sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cells
65. Genetic immunization is a simple method for eliciting an immune response
66. Epstein-Barr virus gp350/220 binding to the B lymphocyte C3d receptor mediates adsorption, capping and endocytosis
67. Modulation of firefly luciferase stability and impact on studies of gene regulation
68. Human cytomegalovirus glycoprotein B contains autonomous determinants for vectorial targeting to apical membranes of polarized epithelial cells
69. Glycoproteins gB, gD, and gHgL of herpes simplex virus type 1 are necessary and sufficient to mediate membrane fusion in a Cos cell transfection system
70. Activation of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) lyric replication by human cytomegalovirus
71. Transmissible Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in saliva of men with a history of Kaposi's sarcoma
72. Human herpesvirus 8 envelope glycoprotein K8. 1A interaction with the target cells involves heparan sulfate
73. Epstein-Barr virus glycoprotein gp85 associates with the BKRF2 gene product and is incompletely processed as a recombinant protein